Characteristics of 2017 GOLD COPD group A: a multicenter cross-sectional CAP study in Japan

References

• National Institute for Health and Clinical Excellence (NICE)Chronic obstructive pulmonary disease in over-16s: diagnosis and managementNICE Guidelines [CG101]LondonNICE2010
   Google Scholar
• FukuchiYNishimuraMIchinoseMCOPD in Japan: the Nippon COPD Epidemiology studyRespirology20049445846515612956
   PubMed Web of Science ®Google Scholar
• BuistASMcburnieMAVollmerWMInternational variation in the prevalence of COPD (the BOLD Study): a population-based prevalence studyLancet2007370958974175017765523
   PubMed Web of Science ®Google Scholar
• From the Global Strategy for the Diagnosis, Management and Prevention of COPDGlobal Initiative for Chronic Obstructive Lung Disease2017 Available from: http://goldcopd.org/gold-2017-global-strategy-diagnosis-management-prevention-copdAccessed July 30, 2018
   Google Scholar
• Cabrera LópezCCasanova MacarioCMarín TrigoJMComparison of the 2017 and 2015 global initiative for chronic obstructive lung disease reports. Impact on grouping and outcomesAm J Respir Crit Care Med2018197446346929099607
   PubMed Web of Science ®Google Scholar
• SunLChenYWuRLuMYaoWChanges in definition lead to changes in the clinical characteristics across COPD categories according to GOLD 2017: a national cross-sectional survey in ChinaInt J Chron Obstruct Pulmon Dis2017123095310229118578
   PubMed Web of Science ®Google Scholar
• MatsunagaKHayataAAkamatsuKStratifying the risk of COPD exacerbation using the modified Medical Research Council scale: a multicenter cross-sectional CAP studyRespir Investig20155328285
   Google Scholar
• MillerMRHankinsonJBrusascoVStandardisation of spirometryEur Respir J200526231933816055882
   PubMed Web of Science ®Google Scholar
• SasakiHNMKidaKReference values for spirogram and blood gas analysis in Japanese adultsJJRS2001395S1S17
   Google Scholar
• MahlerDAWellsCKEvaluation of clinical methods for rating dyspneaChest19889335805863342669
   PubMed Web of Science ®Google Scholar
• VestboJHurdSSAgustíAGGlobal strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summaryAm J Respir Crit Care Med2013187434736522878278
   PubMed Web of Science ®Google Scholar
• PaggiaroPLDahleRBakranIFrithLHollingworthKEfthimiouJMulticentre randomised placebo-controlled trial of inhaled fluticasone propionate in patients with chronic obstructive pulmonary disease. International COPD Study GroupLancet199835191057737809519948
   PubMed Web of Science ®Google Scholar
• KandaYInvestigation of the freely available easy-to-use software ‘EZR’ for medical statisticsBone Marrow Transplant201348345245823208313
   PubMed Web of Science ®Google Scholar
• PerezTBurgelPRPaillasseurJLModified medical research council scale vs baseline dyspnea Index to evaluate dyspnea in chronic obstructive pulmonary diseaseInt J Chron Obstruct Pulmon Dis2015101663167226316740
   PubMed Web of Science ®Google Scholar
• OfirDLavenezianaPWebbKALamYMO’DonnellDEMechanisms of dyspnea during cycle exercise in symptomatic patients with GOLD stage I chronic obstructive pulmonary diseaseAm J Respir Crit Care Med2008177662262918006885
   PubMed Web of Science ®Google Scholar
• ElbehairyAFCiavagliaCEWebbKAPulmonary gas exchange abnormalities in mild chronic obstructive pulmonary disease. implications for dyspnea and exercise intoleranceAm J Respir Crit Care Med2015191121384139425826478
   PubMed Web of Science ®Google Scholar
• ReardonJZLareauSCZuwallackRFunctional status and quality of life in chronic obstructive pulmonary diseaseAm J Med200611910 Suppl 1323716996897
   PubMed Web of Science ®Google Scholar
• HayataAMinakataYMatsunagaKNakanishiMYamamotoNDifferences in physical activity according to mMRC grade in patients with COPDInt J Chron Obstruct Pulmon Dis2016112203220827695306
   PubMed Web of Science ®Google Scholar
• JonesPWAdamekLNadeauGBanikNComparisons of health status scores with MRC grades in COPD: implications for the GOLD 2011 classificationEur Respir J201342364765423258783
   PubMed Web of Science ®Google Scholar
• CasanovaCMarinJMMartinez-GonzalezCDifferential effect of modified medical research council dyspnea, COPD assessment test, and clinical COPD questionnaire for symptoms evaluation within the new GOLD staging and mortality in COPDChest2015148115916825612228
   PubMed Web of Science ®Google Scholar
• KinoshitaMLeeSHHangLWEfficacy and safety of indacaterol 150 and 300 µg in chronic obstructive pulmonary disease patients from six Asian areas including Japan: a 12-week, placebo-controlled studyRespirology201217237938922122202
   PubMed Web of Science ®Google Scholar
• KochAPizzichiniEHamiltonALung function efficacy and symptomatic benefit of olodaterol once daily delivered via Respimat® versus placebo and formoterol twice daily in patients with GOLD 2–4 COPD: results from two replicate 48-week studiesInt J Chron Obstruct Pulmon Dis2014969771425045258
   PubMed Web of Science ®Google Scholar
• VinckenWvan NoordJAGreefhorstAPImproved health outcomes in patients with COPD during 1 yr’s treatment with tiotropiumEur Respir J200219220921611871363
   PubMed Web of Science ®Google Scholar
• MahlerDABuhlRLawrenceDMcbryanDEfficacy and safety of indacaterol and tiotropium in COPD patients according to dyspnoea severityPulm Pharmacol Ther201326334835523434446
   PubMed Web of Science ®Google Scholar
• RodrigoGJPriceDAnzuetoALABA/LAMA combinations versus LAMA monotherapy or LABA/ICS in COPD: a systematic review and meta-analysisInt J Chron Obstruct Pulmon Dis20171290792228360514
   PubMed Web of Science ®Google Scholar
• MinakataYMorishitaYIchikawaTEffects of pharmacologic treatment based on airflow limitation and breathlessness on daily physical activity in patients with chronic obstructive pulmonary diseaseInt J Chron Obstruct Pulmon Dis2015101275128226170656
   PubMed Web of Science ®Google Scholar
• WilkeSSmidDESpruitMAThe 2014 updated GOLD strategy: a comparison of the various scenariosChronic Obstr Pulm Dis20141221222028848823
   PubMedGoogle Scholar
• KimSOhJKimYIDifferences in classification of COPD group using COPD assessment test (CAT) or modified Medical Research Council (mMRC) dyspnea scores: a cross-sectional analysesBMC Pulm Med2013133523731868
   PubMed Web of Science ®Google Scholar
• HuangWCWuMFChenHCHsuJYTOLD GroupFeatures of COPD patients by comparing CAT with mMRC: a retrospective, cross-sectional studyNPJ Prim Care Respir Med2015251506326538368
   PubMed Web of Science ®Google Scholar
• NatoriHKawayamaTSuetomoMEvaluation of the modified medical research council dyspnea scale for predicting hospitalization and exacerbation in Japanese patients with chronic obstructive pulmonary diseaseIntern Med2016551152426726080
   PubMed Web of Science ®Google Scholar